Abiomed, Inc. ABMD
Set alert
381.02 0.00 0.00%
At close · Dec 21
380.55 Day range 381.28
52-week range unavailable
- Open
- 380.78
- Prev close
- 381.02
- Mkt cap
- 17.18B
- Vol
- 15.70M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 380.55
- High
- 381.28
- Forward P/E
- 60.77
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 2, 2023
- 50-d avg
- 351.42
- 200-d avg
- 291.67
- 1y target
- 0.00
MAX chart
Events in this range
- Feb 3, 2022Earnings: —; estimate 0.98; surprise —%
- Apr 28, 2022Earnings: —; estimate 1.08; surprise —%
- Aug 4, 2022Earnings: —; estimate 1.08; surprise —%
- Oct 9, 2022Rating: Piper Sandler · — → Overweight
- Oct 12, 2022Rating: Mizuho · — → Buy
- Oct 31, 2022Downgrade: William Blair · Outperform → Market Perform
- Oct 31, 2022Downgrade: Piper Sandler · Overweight → Neutral
- Nov 1, 2022Earnings: —; estimate 1.05; surprise —%
- Nov 1, 2022Rating: Morgan Stanley · Underweight → Equal-Weight
- Nov 1, 2022Downgrade: Deutsche Bank · Buy → Hold
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 8, 2022 | 3 years ago |
| SMA: Bullish | Nov 8, 2022 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 10, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jul 1, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
Key statistics
- Market cap
- 17.18B
- Trailing P/E
- 65.36
- Forward P/E
- 60.77
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 351.42
- 200-day average
- 291.67
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Ratings (0m) 10 8 buy · 2 hold · 0 sell
- Strong buy5
- Buy3
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 2, 2023
Expected Feb 2, 2023. Consensus EPS estimate 0.00.
Financials — quick view
ABMD Revenue — quarterly 265.92M
ABMD Net income — quarterly 106.13M
ABMD EPS — quarterly 2.34
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 2, 2023 | Dec 1, 2022 | 1.03 | — | — | — |
| Nov 1, 2022 | Sep 1, 2022 | 1.05 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | 1.08 | — | — | — |
| Apr 28, 2022 | Mar 1, 2022 | 1.08 | — | — | — |
| Feb 3, 2022 | Dec 1, 2021 | 0.98 | — | — | — |
| Oct 28, 2021 | Sep 1, 2021 | 0.98 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 1, 2022 | Morgan Stanley | up | Underweight | Equal-Weight |
| Nov 1, 2022 | Deutsche Bank | down | Buy | Hold |
| Oct 31, 2022 | William Blair | down | Outperform | Market Perform |
| Oct 31, 2022 | Piper Sandler | down | Overweight | Neutral |
| Oct 12, 2022 | Mizuho | init | — | Buy |
| Oct 9, 2022 | Piper Sandler | main | — | Overweight |
News
- Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.
- IoMT Wearable Devices Patent Landscape Report and Forecasts, 2017-2023 & 2024-2032 Featuring Veniam, Advanced Neuromodulation Systems, Bionet Sonar, and Abiomed
- US FDA classifies recall of Abiomed's blood pumps as most serious
- 3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio
- FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
- Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
- Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, OPNT, BNFT, ABMD
- First Patients in the World Treated with Impella RP Flex with SmartAssist
- Eleven Stocks Turned $10,000 To $261,421 In 11 Months
Your note
Sign in to keep a note on ABMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEGAN MARC A. | General Counsel | Sale | Nov 3, 2022 | 12,237 |
| GREENFIELD ANDREW J | Officer | Stock Award(Grant) | Dec 15, 2022 | 15,977 |
| MINOGUE MICHAEL R | Chief Executive Officer | Stock Award(Grant) | Dec 15, 2022 | 380,048 |
| PLANO MATTHEW T | Officer | Sale | Oct 31, 2022 | 10,270 |
| RIVET JEANNINE M. | Director | Stock Award(Grant) | Aug 9, 2022 | 9,966 |
| ROSE ERIC A | Director | Stock Award(Grant) | Aug 9, 2022 | 15,203 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 11.69% | 5,269,340 | 1.29B | Sep 29, 2022 |
| Blackrock Inc. | 10.11% | 4,560,483 | 1.12B | Sep 29, 2022 |
| Baillie Gifford and Company | 8.04% | 3,624,937 | 890.50M | Sep 29, 2022 |
| State Street Corporation | 4.59% | 2,071,180 | 508.81M | Sep 29, 2022 |
| Primecap Management Company | 3.34% | 1,506,272 | 370.03M | Sep 29, 2022 |
| Wellington Management Group, LLP | 3.22% | 1,453,669 | 357.11M | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.00% | 1,354,236 | 332.68M | Sep 29, 2022 |
| Vanguard U.S. Growth Fund | 2.70% | 1,216,666 | 315.46M | Aug 30, 2022 |
| Vanguard Mid-Cap Index Fund | 2.33% | 1,049,159 | 257.74M | Sep 29, 2022 |
| Vanguard 500 Index Fund | 2.29% | 1,030,404 | 253.13M | Sep 29, 2022 |
| Mainstay Winslow Large Cap Growth Fund | 1.71% | 769,500 | 225.47M | Jul 30, 2022 |
| Primecap Odyssey Aggressive Growth Fund | 1.68% | 758,623 | 186.36M | Sep 29, 2022 |